Page 1

1. Results ( July 2021 to September 2021 ) ( 1 ) Sales Lasertec Corporation ( 6920 ) First 3 Months of Fiscal Year ending June 2022 - 1on1 FAQ Sales totaled JPY 9.1B ( down 4.0B YoY ) 11.0 % progress vs. 83.0B forecast of sales for FY2022 → Slow progress , but it is due to the timing of acceptance ; no change to full - year forecast " Semiconductor - related products " accounted for 6.6B ( down 4.4B YoY ) " Other products " accounted for > 0.1B ( down < 0.4B YoY ) " Services " accounted for 2.3B ( up > 0.7B YoY ) ( Note : There are large fluctuations in sales , expenses , and profits on a quarterly basis . ) Gross profit amounted to 5.3B ( down 1.5B YoY ) , and GP margin 58.6 % ( + 6.6 % YoY ) → Products with higher profit margins accepted by customer at a faster pace than others , pushing profit margin higher than expected for FY2022 ( 2 ) Orders ● Operating profit amounted to 2.0B ( down 2.5B YoY ) , and OP margin 22.2 % ( -12.2 % YoY ) → SG & A expenses steadily incurred regardless of slow progress in sales , raising the ratio of SG & A expenses to sales Net profit amounted to 1.5B ( down 1.5B YoY ) , and NP margin 17.2 % ( -6.8 % YoY ) October 29 , 2021 Orders totaled 108.3B ( up 83.9B YoY ) , and backlog at the end of the period amounted to 235.0B ( up 130.6B YoY ) → 67.7 % progress vs. 160.0B forecast of orders for FY2022 → Quick progress , but it is due to the timing of orders ; no change to full - year forecast → Driven by EUV - related products including ACTIS and MATRICS X8ULTRA mainly for Asia " Semiconductor - related products " accounted for 105.6B ( up 82.7B YoY ) " Other products " accounted for > 0.2B ( up > 0.0B YOY ) " Services " accounted for 2.4B ( up 1.1B YoY ) ( 3 ) Income statement R & D expenses amounted to 2.1B , 23.5 % of sales ( up 1.0B YoY ) → 28.6 % progress vs. 7.5B forecast of R & D expenses for FY2022 → R & D expenses incurred at expected pace regardless of slow progress in sales , raising the ratio of R & D expenses to sales Depreciation and amortization amounted to 0.8B ( up > 0.6B YoY ) → 25.8 % progress vs. 3.2B forecast of depreciation and amortization for FY2022 Capital expenditure amounted to 4.6B ( up 4.4B YoY ) 101.9 % progress vs. 4.5B forecast of capital expenditure for FY2022 Proactive investment ( in intangible assets ) made in Q1 to strengthen EUV - related business ( 4 ) Balance sheet & cash flows Cash and deposits at the end of the period was 23.2B ( down 4.7B from the end of FY2021 ) 1